Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines set out in the Schedule hereto:
Schedule
Product: Foban
Active Ingredient: Sodium fusidate 2%w/w
Dosage Form: Topical ointment
New Zealand Sponsor: AFT Pharmaceuticals Limited
Manufacturer: Hoe Pharmaceuticals Sdn. Bhd., Bandar Sultan Suleiman, Pelabuhan Klang, Selangor, Malaysia
Product: Levemir Flexpen
Active Ingredient: Insulin detemir 100U/mL
Dosage Form: Solution for injection
New Zealand Sponsor: Novo Nordisk Pharmaceuticals Limited
Manufacturers: Novo Nordisk A/S, Brennum Park, Hillerod, Denmark
Novo Nordisk A/S, Bagsvaerd, Copenhagen, Denmark
Product: Levemir Innolet
Active Ingredient: Insulin detemir 100U/mL
Dosage Form: Solution for injection
New Zealand Sponsor: Novo Nordisk Pharmaceuticals Limited
Manufacturers: Novo Nordisk A/S, Brennum Park, Hillerod, Denmark
Novo Nordisk A/S, Bagsvaerd, Copenhagen, Denmark
Product: Levemir Penfill
Active Ingredient: Insulin detemir 100U/mL
Dosage Form: Solution for injection
New Zealand Sponsor: Novo Nordisk Pharmaceuticals Limited
Manufacturers: Novo Nordisk A/S, Brennum Park, Hillerod, Denmark
Novo Nordisk A/S, Bagsvaerd, Copenhagen, Denmark
Dated this 2nd day of April 2005.
DON MATHESON, Deputy Director-General, Public Health (pursuant to delegation given by the Minister of Health on 6 July 2001).